Sergio Iván Valdés‐Ferrer

5.0k total citations · 2 hit papers
62 papers, 3.2k citations indexed

About

Sergio Iván Valdés‐Ferrer is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Sergio Iván Valdés‐Ferrer has authored 62 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Neurology and 14 papers in Neurology. Recurrent topics in Sergio Iván Valdés‐Ferrer's work include Vagus Nerve Stimulation Research (14 papers), Nicotinic Acetylcholine Receptors Study (9 papers) and Sepsis Diagnosis and Treatment (7 papers). Sergio Iván Valdés‐Ferrer is often cited by papers focused on Vagus Nerve Stimulation Research (14 papers), Nicotinic Acetylcholine Receptors Study (9 papers) and Sepsis Diagnosis and Treatment (7 papers). Sergio Iván Valdés‐Ferrer collaborates with scholars based in United States, Mexico and Canada. Sergio Iván Valdés‐Ferrer's co-authors include Kevin J. Tracey, Sangeeta S. Chavan, Peder S. Olofsson, Mauricio Rosas‐Ballina, Mahendar Ochani, Valentin A. Pavlov, Jan Andersson, Yaakov A. Levine, Colin Reardon and Michael W. Tusche and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Sergio Iván Valdés‐Ferrer

60 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit

2011 1.1k citations Mauricio Rosas‐Ballina, Peder S. Olofsson et al. profile →
Novel role of PKR in inflammasome activation and HMGB1 release

2012 632 citations Sergio Iván Valdés‐Ferrer, Peder S. Olofsson et al. profile →

Peers

Countries citing papers authored by Sergio Iván Valdés‐Ferrer

Since Specialization

Citations

This map shows the geographic impact of Sergio Iván Valdés‐Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Iván Valdés‐Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Iván Valdés‐Ferrer more than expected).

Fields of papers citing papers by Sergio Iván Valdés‐Ferrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Iván Valdés‐Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Iván Valdés‐Ferrer. The network helps show where Sergio Iván Valdés‐Ferrer may publish in the future.

Co-authorship network of co-authors of Sergio Iván Valdés‐Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Iván Valdés‐Ferrer. A scholar is included among the top collaborators of Sergio Iván Valdés‐Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Iván Valdés‐Ferrer. Sergio Iván Valdés‐Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sepsis Impairs IFN-γ Production in CD8 T Cells through Changes in Local Chromatin Landscape 2024 ·The Journal of Immunology ·(unknown), Noé Rodríguez‐Rodríguez, (unknown), (unknown), Carlos A. Rodríguez-Osorio, Sergio Iván Valdés‐Ferrer, (unknown), Félix Recillas‐Targa, Iris K. Madera‐Salcedo, Florencia Rosetti, José C. Crispín	0
2	Retiring the term AIDS for more descriptive language 2024 ·The Lancet HIV ·(unknown), Alicia Menendez, Sergio Iván Valdés‐Ferrer	2
3	Vagus nerve stimulation primes platelets and reduces bleeding in hemophilia A male mice 2023 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Téa Tsaava, (unknown), (unknown), (unknown), (unknown), Meghan E. Addorisio, Sergio Iván Valdés‐Ferrer, Sangeeta S. Chavan, Lionel Blanc, Christopher J. Czura, Kevin J. Tracey, Jared M. Huston	5
4	Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico 2023 ·Frontiers in Public Health ·(unknown), (unknown), Neftalí Eduardo Antonio-Villa, Carlos A. Fermín‐Martínez, (unknown), Arsenio Vargas‐Vázquez, (unknown), (unknown), Hugo López‐Gatell, Sergio Iván Valdés‐Ferrer, Omar Yaxmehen Bello‐Chavolla	8
5	Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes 2022 ·Lupus ·Miguel García‐Grimshaw, (unknown), Amado Jiménez‐Ruiz, Sergio Iván Valdés‐Ferrer, (unknown), Jiram Torres‐Ruiz, (unknown), (unknown), Erwin Chiquete, (unknown), Carlos Cantú‐Brito	9
6	Hospitalization as an outcome in ambulatory COVID-19 trials—not applicable in every setting 2022 ·Clinical Microbiology and Infection ·Isaac Núñez, Sergio Iván Valdés‐Ferrer, Adrián Soto-Mota	2
7	Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study 2022 ·The Lancet Regional Health - Americas ·Isaac Núñez, Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, (unknown), (unknown), (unknown), (unknown), Ricardo Cortés-Alcalá, (unknown), (unknown), (unknown), Hugo López‐Gatell, Gustavo Reyes‐Terán, Sergio Iván Valdés‐Ferrer	34
8	Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study 2021 ·Vaccine ·Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, (unknown), (unknown), (unknown), Javier Andrés Galnares‐Olalde, (unknown), (unknown), (unknown), Laura E. Hernández‐Vanegas, (unknown), (unknown), José Luis Díaz‐Ortega, Gustavo Reyes‐Terán, Hugo López‐Gatell, (unknown), Carlos Cantú‐Brito, Erwin Chiquete, Antonio Araúz, Sergio Iván Valdés‐Ferrer	7
9	Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City 2021 ·PLoS ONE ·(unknown), Miguel García‐Grimshaw, Sergio Iván Valdés‐Ferrer, (unknown), (unknown), (unknown), (unknown), Alejandra González‐Duarte, (unknown), (unknown), Amado Jiménez‐Ruiz, (unknown), (unknown), (unknown), (unknown), Guillermo García‐Ramos, Carlos Cantú‐Brito, Erwin Chiquete	39
10	Detection of Pulmonary Shunts by Transcranial Doppler in Hospitalized Non-mechanically Ventilated Coronavirus Disease-19 Patients 2021 ·Revista de investigaci�n Cl�nica ·(unknown), Miguel García‐Grimshaw, Sergio Iván Valdés‐Ferrer, (unknown), Eduardo R. Argaiz, (unknown), Eduardo Rivero-Sigarroa, Amado Jiménez‐Ruiz, Erwin Chiquete, Carlos Cantú‐Brito, (unknown)	3
11	Primary central nervous system lymphoma in a patient treated with mycophenolate mofetil for lupus nephritis 2020 ·Neurology and Clinical Neuroscience ·Miguel García‐Grimshaw, Amado Jiménez‐Ruiz, (unknown), (unknown), Ana Barrera‐Vargas, Sergio Iván Valdés‐Ferrer	1
12	The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation 2020 ·Molecular Medicine ·Ravikumar Sitapara, Alex Gauthier, Sergio Iván Valdés‐Ferrer, (unknown), Vivek Patel, Mao Wang, Ashley T. Martino, Jeanette C. Perron, Charles R. Ashby, Kevin J. Tracey, Valentin A. Pavlov, Lin L. Mantell	34
13	The vagus neurometabolic interface and clinical disease 2018 ·International Journal of Obesity ·(unknown), Sergio Iván Valdés‐Ferrer, Benjamin E. Steinberg	25
14	Radiotherapy induced cavernomas in adult cancer patients 2018 ·Radiotherapy and Oncology ·Bernardo Cacho‐Díaz, (unknown), (unknown), (unknown), Sergio Iván Valdés‐Ferrer, (unknown), Gervith Reyes-Soto, Ángel Herrera‐Gómez	4
15	Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation 2014 ·Brain Behavior and Immunity ·Mauricio Rosas‐Ballina, Sergio Iván Valdés‐Ferrer, Meghan Dancho, Mahendar Ochani, David A. Katz, Kai Cheng, Peder S. Olofsson, Sangeeta S. Chavan, Yousef Al‐Abed, Kevin J. Tracey, Valentin A. Pavlov	64
16	Neural Signaling in the Spleen Controls B-Cell Responses to Blood-Borne Antigen 2012 ·Molecular Medicine ·Paola Mina‐Osorio, Mauricio Rosas‐Ballina, Sergio Iván Valdés‐Ferrer, Yousef Al‐Abed, Kevin J. Tracey, Betty Diamond	56
17	Vagus Nerve Stimulation Produces an Anti-Inflammatory Monocyte Phenotype in Blood. (138.25) 2010 ·The Journal of Immunology ·Sergio Iván Valdés‐Ferrer, Mauricio Rosas‐Ballina, Peder S. Olofsson, Sangeeta S. Chavan, Kevin J. Tracey	5
18	Neural control of acetylcholine release by T cells attenuates TNF production in endotoxemia (138.24) 2010 ·The Journal of Immunology ·Mauricio Rosas‐Ballina, Mahendar Ochani, Peder S. Olofsson, Sergio Iván Valdés‐Ferrer, Sangeeta S. Chavan, Kevin J. Tracey	1
19	Acetylcholine-Esterase Inhibitor Pyridostigmine Decreases T Cell Overactivation in Patients Infected by HIV 2009 ·AIDS Research and Human Retroviruses ·Sergio Iván Valdés‐Ferrer, José C. Crispín, Pablo F. Belaunzarán-Zamudio, Carlos Cantú‐Brito, Juan Sierra‐Madero, Jorge Alcocer‐Varela	13
20	Clinical Description of Intracranial Hemorrhage Associated with Bleeding Disorders 2008 ·Journal of Stroke and Cerebrovascular Diseases ·Alejandra González‐Duarte, Guillermo García‐Ramos, Sergio Iván Valdés‐Ferrer, Carlos Cantú‐Brito	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact